BRAK Human (A61323)

BRAK Human

BRAK (CXCL14) Human Recombinant

Escherichia Coli.

The sequence of the first five N-terminal amino acids was determined and was found to be Ser-Lys-Cys-Lys-Cys.

Greater than 95.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE.

Lyophilized CXCL14 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution CXCL14 should be stored at 4°C between 2-7 days and for future use below -18°C.Please prevent freeze-thaw cycles.

1110031L23Rik, 1200006I23Rik, AI414372, BMAC, bolekine, Breast and kidney, C-X-C motif chemokine 14, C-X-C motif chemokine ligand 14, Chaemokine, CXC motif, ligand 14, Chemokine (C-X-C motif) ligand 14, Chemokine BRAK, CXC chemokine in breast and kidney, CXCL14, CXL14_HUMAN, JSC, Kec, Kidney-expressed chemokine CXC, KS1, MGC10687, MGC124510, MGC90667, MIP 2 gamma, MIP-2G, MIP2G, MIP2gamma, NJAC, PRO273, PSEC0212, Scyb14, Small Inducible Cytokine B14, Small inducible cytokine subfamily B (Cys-X-Cys) member 14 (BRAK), Small Inducible Cytokine subfamily B, member 14, Small-inducible cytokine B14, Tumor suppressing chemokine, UNQ240